Neurology
Motor Neurone Disease: Investigating if specific toxins contribute towards to the onset of MND
Research Objectives
Status
Completed
Recruitment
Closed
Study location
Wesley Research Institute, The University of Queensland
Study type
Investigator Initiated
Lead investigator
- Prof Pamela McCombe (UQ)
Experienced investigator
- Dr Aven Lee (UQ)
About this research project
Motor neurone disease (MND) is a severe disease for which there is no successful therapy. Currently there is no cure for MND. The best approach in clinical practice is primary prevention through the modification of risk factors.
In a novel study previously funded by Wesley Research Institute, we have demonstrated that MND patients have increased levels of homocysteine sulfinic acid, an excitotoxin that can be produced by the gut microbiota.
In this follow up study, we will investigate if the increases in these excitotoxins change during disease progression and correlate with survival. These toxins could contribute to the onset of MND. It’s possible that eliminating these gut toxins could lead to better patient outcomes.
Latest News
Thank you to all who joined our Advocates Event – Spatial Biology: A New Frontier of Precision Medicine
On 24 Nov, the Wesley Hospital Auditorium saw a community of medical research advocates come together to learn more about spatial biology and the latest research efforts from the Wesley Research Institute's Queensland Spatial Biology Centre.
The Impact of Financial Stress of a Gluten-Free Diet for People with Coeliac Disease: New Research in Australia
WRI researchers are calling upon people living with coeliac disease in Australia to participate in research to map the quality of life in this current cost-of-living crisis and whether this is impacting their ability to adhere to a gluten-free diet.
Give Hope a Name This Christmas
Your support can play a vital role in advancing life-changing research at Wesley Research Institute. Our scientists are uncovering new ways to personalise treatment and improve outcomes for people facing serious illnesses, like cancer.